Similar articles

• Evaluating the Incidence of Opioid-Induced Respiratory Depression Associated with Oliceridine and Morphine as Measured by the Frequency and Average Cumulative Duration of Dosing Interruption in Patients Treated for Acute Postoperative Pain.

  Ayad S, Demitrack MA, Burt DA, Michalsky C, Wase L, Fossler MJ, Khanna AK. Ayad S, et al. Clin Drug Investig. 2020 Aug;40(8):755-764. doi: 10.1007/s40261-020-00936-0. Clin Drug Investig. 2020. PMID: 32583295 Free PMC article.
• Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers.

  Soergel DG, Subach RA, Burnham N, Lark MW, James IE, Sadler BM, Skobieranda F, Violin JD, Webster LR. Soergel DG, et al. Pain. 2014 Sep;155(9):1829-1835. doi: 10.1016/j.pain.2014.06.011. Epub 2014 Jun 19. Pain. 2014. PMID: 24954166 Clinical Trial.
• Oliceridine, a G protein-selective ligand at the μ-opioid receptor, for the management of moderate to severe acute pain.

  Gan TJ, Wase L. Gan TJ, et al. Drugs Today (Barc). 2020 Apr;56(4):269-286. doi: 10.1358/dot.2020.56.4.3107707. Drugs Today (Barc). 2020. PMID: 32309822
• Safety evaluation of oliceridine for the management of postoperative moderate-to-severe acute pain.

  Tan HS, Habib AS. Tan HS, et al. Expert Opin Drug Saf. 2021 Nov;20(11):1291-1298. doi: 10.1080/14740338.2021.1965989. Epub 2021 Aug 20. Expert Opin Drug Saf. 2021. PMID: 34370562 Review.
• The Utilization of Mu-Opioid Receptor Biased Agonists: Oliceridine, an Opioid Analgesic with Reduced Adverse Effects.

  Urits I, Viswanath O, Orhurhu V, Gress K, Charipova K, Kaye AD, Ngo A. Urits I, et al. Curr Pain Headache Rep. 2019 Mar 18;23(5):31. doi: 10.1007/s11916-019-0773-1. Curr Pain Headache Rep. 2019. PMID: 30880365 Review.